JNBA Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

JNBA Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$61.4K	Hold	2,038	–	–	0.01%	281
2025 Q4	$63.6K	Buy	2,038 +38	+2%	+$936	0.01%	282
2025 Q3	$40.4K	Hold	2,000	–	–	﹤0.01%	329
2025 Q2	$33.5K	Hold	2,000	–	–	﹤0.01%	338
2025 Q1	$30.7K	Hold	2,000	–	–	﹤0.01%	334
2024 Q4	$44.1K	Hold	2,000	–	–	﹤0.01%	300
2024 Q3	$36K	Hold	2,000	–	–	﹤0.01%	324
2024 Q2	$32.5K	Hold	2,000	–	–	﹤0.01%	329
2024 Q1	$28.2K	Hold	2,000	–	–	﹤0.01%	352
2023 Q4	$20.9K	Hold	2,000	–	–	﹤0.01%	386
2023 Q3	$20.4K	Hold	2,000	–	–	﹤0.01%	383
2023 Q2	$15.1K	Hold	2,000	–	–	﹤0.01%	421
2023 Q1	$17.7K	Hold	2,000	–	–	﹤0.01%	408
2022 Q4	$18.2K	Hold	2,000	–	–	﹤0.01%	383
2022 Q3	$16K	Hold	2,000	–	–	﹤0.01%	409
2022 Q2	$15K	Hold	2,000	–	–	﹤0.01%	443
2022 Q1	$19K	Sell	2,000 -900	-31%	-$7.51K	﹤0.01%	416
2021 Q4	$23K	Buy	2,900 +500	+21%	+$4.51K	﹤0.01%	397
2021 Q3	$23K	Hold	2,400	–	–	﹤0.01%	398
2021 Q2	$24K	Hold	2,400	–	–	﹤0.01%	378
2021 Q1	$28K	Buy	2,400 +400	+20%	+$4.59K	﹤0.01%	350
2020 Q4	$19K	Hold	2,000	–	–	﹤0.01%	372
2020 Q3	$18K	Hold	2,000	–	–	﹤0.01%	361
2020 Q2	$25K	Hold	2,000	–	–	0.01%	304
2020 Q1	$18K	Hold	2,000	–	–	﹤0.01%	319
2019 Q4	$20K	Buy	+2,000	New	+$17.9K	﹤0.01%	351
2019 Q3	–	Sell	-700	Closed	-$6K	–	697
2019 Q2	$6K	Buy	700 +100	+17%	+$1.21K	﹤0.01%	499
2019 Q1	$9K	Hold	600	–	–	﹤0.01%	413
2018 Q4	$9K	Buy	+600	New	+$12.3K	﹤0.01%	390
2018 Q3	–	Sell	-600	Closed	-$15K	–	695
2018 Q2	$15K	Buy	600 +500	+500%	+$10.2K	﹤0.01%	350
2018 Q1	$2K	Sell	100 -32	-24%	-$625	﹤0.01%	466
2017 Q4	$3K	Sell	132 -1,637	-93%	-$24.6K	﹤0.01%	435
2017 Q3	$31K	Hold	1,769	–	–	0.01%	260
2017 Q2	$59K	Buy	1,769 +475	+37%	+$14.7K	0.01%	192
2017 Q1	$42K	Hold	1,294	–	–	0.01%	216
2016 Q4	$47K	Sell	1,294 -3,310	-72%	-$132K	0.01%	211
2016 Q3	$212K	Buy	4,604 +3,009	+189%	+$157K	0.03%	212
2016 Q2	$80K	Hold	1,595	–	–	0.02%	173
2016 Q1	$85K	Hold	1,595	–	–	0.03%	157
2015 Q4	$105K	Sell	1,595 -75	-4%	-$4.63K	0.04%	144
2015 Q3	$94K	Sell	1,670 -193	-10%	-$12.5K	0.04%	139
2015 Q2	$110K	Sell	1,863 -468	-20%	-$28.9K	0.04%	122
2015 Q1	$145K	Hold	2,331	–	–	0.06%	109
2014 Q4	$134K	Sell	2,331 -50	-2%	-$2.79K	0.05%	113
2014 Q3	$128K	Buy	2,381 +32	+1%	+$1.7K	0.06%	113
2014 Q2	$123K	Hold	2,349	–	–	0.06%	110
2014 Q1	$124K	Sell	2,349 -800	-25%	-$37K	0.07%	106
2013 Q4	$126K	Sell	3,149 -1,972	-39%	-$77.7K	0.07%	102
2013 Q3	$193K	Sell	5,121 -500	-9%	-$19.5K	0.12%	86
2013 Q2	$220K	Buy	+5,621	New	+$219K	0.15%	79

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JNBA Financial Advisors's TEVA Position: Q1 2026 in Review

JNBA Financial Advisors held its Teva Pharmaceuticals (TEVA) position steady in Q1 2026 at 2,038 shares worth $61.4K. The position accounts for 0.01% of the portfolio, ranked #281.

JNBA Financial Advisors first reported a position in TEVA in Q2 2013 and has held it in 50 quarters since. The position peaked at $220K in Q2 2013. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

JNBA Financial Advisors held 2,038 shares of Teva Pharmaceuticals worth $61.4K as of Q1 2026.
JNBA Financial Advisors left its Teva Pharmaceuticals share count unchanged in Q1 2026.
Teva Pharmaceuticals made up 0.01% of JNBA Financial Advisors's portfolio in Q1 2026, its #281 holding.
JNBA Financial Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
JNBA Financial Advisors's Teva Pharmaceuticals position peaked at $220K in Q2 2013.
650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on JNBA Financial Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.